Association of Life's Essential 8 and Life's Simple 7 with metabolic-associated fatty liver disease in the United States

被引:1
|
作者
Fu, Wei [1 ]
Cheng, Guo-Bin [2 ]
Zhao, Jun-Long [3 ]
Lv, Lin-Ya [2 ]
Ding, Yao [2 ]
机构
[1] 925 PLA, Dept Gastroenterol, 67 Huanghelu, Guiyang 550009, Guizhou, Peoples R China
[2] 925 Hosp PLA Joint Logist Support Force, Dept Gastroenterol, Guiyang 550009, Guizhou, Peoples R China
[3] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China
关键词
Cardiovascular health; Life's Essential 8; Life's Simple 7; Metabolic-associated fatty liver disease; National Health And Nutrition Examination Survey; AMERICAN HEART ASSOCIATIONS;
D O I
10.4254/wjh.v17.i2.97741
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Cardiovascular health (CVH) plays a crucial role in overall health, but its association with metabolic-associated fatty liver disease (MAFLD) remains unclear. AIM To investigate the relationship between CVH, measured using Life's Essential 8 (LE8) and Life's Simple 7 (LS7), and the prevalence of MAFLD. METHODS This cross-sectional study had a sample of 2234 individuals, representing approximately 120 million individuals in the United States. Baseline parameters were compared between the LE8 and LS7 groups. Logistic regression models were used to evaluate the relationship between LE8, LS7, and MAFLD, while taking into account confounding factors. The investigation employed restricted cubic splines to investigate non-linear associations. Subgroup analyses and sensitivity studies were performed to evaluate the strength and reliability of the results. RESULTS Higher LE8 and LS7 scores were significantly associated with a decreased risk of MAFLD, even after controlling for demographic, socioeconomic, and clinical variables. This association demonstrated a non-linear pattern, with the most dramatic risk reduction observed at higher CVH levels. Individual CVH components, notably healthy behaviors and factors, exhibited strong relationships with MAFLD. Subgroup analyses indicated consistent relationships across several demographics. Sensitivity tests utilizing other MAFLD definitions validated the robustness of the findings. CONCLUSION Higher adherence to CVH criteria, as indicated by LE8 and LS7 scores, is associated with a significantly lower risk of MAFLD. These results emphasize the need to advance CVH to control and avoid MAFLD.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Epigenetic Age Mediates the Association of Life's Essential 8 With Cardiovascular Disease and Mortality
    Carbonneau, Madeleine
    Li, Yi
    Prescott, Brenton
    Liu, Chunyu
    Huan, Tianxiao
    Joehanes, Roby
    Murabito, Joanne M.
    Heard-Costa, Nancy L.
    Xanthakis, Vanessa
    Levy, Daniel
    Ma, Jiantao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11): : e032743
  • [42] Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease
    Zhang, Hang
    Dong, Xuan
    Zhu, Lei
    Tang, Fu-Shan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (40) : 4393 - 4398
  • [43] The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
    Olveira, Antonio
    Augustin, Salvador
    Benlloch, Salvador
    Ampuero, Javier
    Suarez-Perez, Jorge Alonso
    Armesto, Susana
    Vilarrasa, Eva
    Belinchon-Romero, Isabel
    Herranz, Pedro
    Crespo, Javier
    Guimera, Francisco
    Gomez-Labrador, Lara
    Martin, Victor
    Carrascosa, Jose Manuel
    LIFE-BASEL, 2023, 13 (02):
  • [44] Shifts in the Bacterial Community of Supragingival Plaque Associated With Metabolic-Associated Fatty Liver Disease
    Zhao, Fen
    Dong, Ting
    Yuan, Ke-Yong
    Wang, Ning-Jian
    Xia, Fang-Zhen
    Liu, Di
    Wang, Zhi-Min
    Ma, Rui
    Lu, Ying-Li
    Huang, Zheng-Wei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [45] Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood
    de Groot, Jasmin
    Santos, Susana
    Geurtsen, Madelon L.
    Felix, Janine F.
    Jaddoe, Vincent W. V.
    ECLINICALMEDICINE, 2023, 65
  • [46] Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease
    Bae, Jaehyun
    Lee, Byung-Wan
    BIOMEDICINES, 2023, 11 (07)
  • [47] Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
    Alomari, Mohammad
    Rashid, Mamoon Ur
    Chadalavada, Pravallika
    Ragheb, Jonathan
    Zafar, Hammad
    Suarez, Zoilo Karim
    Khazaaleh, Shrouq
    Gonzalez, Adalberto Jose
    Castro, Fernando J.
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) : 477 - 496
  • [48] Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
    Fouad, Yasser
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (02) : 123 - 128
  • [49] The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome
    Vidal-Cevallos, Paulina
    Mijangos-Trejo, Alejandra
    Uribe, Misael
    Tapia, Norberto Chavez
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 533 - 545
  • [50] Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components
    Ran, Dongsheng
    Xin, ChunLing
    Ma, Yingcai
    Lu, Yanyan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (03)